Mirae Asset Global Investments
NVAX icon

Mirae Asset Global Investments’s Novavax NVAX Stock Holding History

Mirae Asset Global Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.3K Sell
7,354
-1,145
-13% -$10.3K ﹤0.01% 1313
2026
Q1 		$69.2K Buy
8,499
+603
+8% +$5.47K ﹤0.01% 1237
2025
Q4 		$53.1K Buy
7,896
+1,617
+26% +$12.2K ﹤0.01% 1384
2025
Q3 		$54.4K Buy
6,279
+22
+0.4% +$171 ﹤0.01% 1327
2025
Q2 		$39.4K Buy
6,257
+875
+16% +$5.79K ﹤0.01% 1295
2025
Q1 		$37.7K Buy
5,382
+44
+0.8% +$364 ﹤0.01% 1295
2024
Q4 		$44.2K Sell
5,338
-452
-8% -$4.36K ﹤0.01% 1283
2024
Q3 		$77K Buy
5,790
+1,598
+38% +$20.6K ﹤0.01% 1229
2024
Q2 		$53.8K Sell
4,192
-50,800
-92% -$511K ﹤0.01% 1231
2024
Q1 		$263K Sell
54,992
-44,322
-45% -$206K ﹤0.01% 2162
2023
Q4 		$477K Buy
99,314
+23,715
+31% +$145K ﹤0.01% 1987
2023
Q3 		$547K Sell
75,599
-5,852
-7% -$46.8K ﹤0.01% 1836
2023
Q2 		$611K Buy
81,451
+31,983
+65% +$252K ﹤0.01% 1851
2023
Q1 		$343K Buy
+49,468
New +$455K ﹤0.01% 2100
2021
Q4 		– Sell
-2,163
Closed -$448K – 1699
2021
Q3 		$448K Buy
2,163
+534
+33% +$118K ﹤0.01% 1516
2021
Q2 		$346K Buy
+1,629
New +$298K ﹤0.01% 1553

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Mirae Asset Global Investments's NVAX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Novavax (NVAX) stake by 13% in Q2 2026, selling an estimated $10.3K and leaving 7,354 shares worth $69.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1313.

Mirae Asset Global Investments first reported a position in NVAX in Q2 2021 and has held it in 16 quarters since. The position peaked at $611K in Q2 2023. 104 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Mirae Asset Global Investments held 7,354 shares of Novavax worth $69.3K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,145 Novavax shares in Q2 2026, an estimated $10.3K.
  • Novavax made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1313 holding.
  • Mirae Asset Global Investments first reported a position in Novavax in Q2 2021 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Novavax position peaked at $611K in Q2 2023.
  • 104 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.